The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Serological Transplant Diagnostics Market Research Report 2025
Synopsis
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
The global Serological Transplant Diagnostics market was valued at US$ 345.5 million in 2023 and is anticipated to reach US$ 405.7 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Serological Transplant Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serological Transplant Diagnostics.
Report Scope
The Serological Transplant Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Serological Transplant Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Serological Transplant Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Segment by Type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Segment by Application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Serological Transplant Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
The global Serological Transplant Diagnostics market was valued at US$ 345.5 million in 2023 and is anticipated to reach US$ 405.7 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Serological Transplant Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serological Transplant Diagnostics.
Report Scope
The Serological Transplant Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Serological Transplant Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Serological Transplant Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Segment by Type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Segment by Application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Serological Transplant Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Serological Transplant Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kidney Transplantation
1.2.3 Liver Transplantation
1.2.4 Heart Transplantation
1.2.5 Lung Transplantation
1.2.6 Pancreas Transplantation
1.3 Market by Application
1.3.1 Global Serological Transplant Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals, Blood Banks and Transplant Centers
1.3.3 Donor Registries and Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Serological Transplant Diagnostics Market Perspective (2019-2030)
2.2 Serological Transplant Diagnostics Growth Trends by Region
2.2.1 Global Serological Transplant Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Serological Transplant Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Serological Transplant Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Serological Transplant Diagnostics Market Dynamics
2.3.1 Serological Transplant Diagnostics Industry Trends
2.3.2 Serological Transplant Diagnostics Market Drivers
2.3.3 Serological Transplant Diagnostics Market Challenges
2.3.4 Serological Transplant Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Serological Transplant Diagnostics Players by Revenue
3.1.1 Global Top Serological Transplant Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Serological Transplant Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Serological Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Serological Transplant Diagnostics Revenue
3.4 Global Serological Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Serological Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Serological Transplant Diagnostics Revenue in 2023
3.5 Serological Transplant Diagnostics Key Players Head office and Area Served
3.6 Key Players Serological Transplant Diagnostics Product Solution and Service
3.7 Date of Enter into Serological Transplant Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Serological Transplant Diagnostics Breakdown Data by Type
4.1 Global Serological Transplant Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Serological Transplant Diagnostics Forecasted Market Size by Type (2025-2030)
5 Serological Transplant Diagnostics Breakdown Data by Application
5.1 Global Serological Transplant Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Serological Transplant Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Serological Transplant Diagnostics Market Size (2019-2030)
6.2 North America Serological Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Serological Transplant Diagnostics Market Size by Country (2019-2024)
6.4 North America Serological Transplant Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Serological Transplant Diagnostics Market Size (2019-2030)
7.2 Europe Serological Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Serological Transplant Diagnostics Market Size by Country (2019-2024)
7.4 Europe Serological Transplant Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Serological Transplant Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Serological Transplant Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Serological Transplant Diagnostics Market Size (2019-2030)
9.2 Latin America Serological Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Serological Transplant Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Serological Transplant Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Serological Transplant Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Serological Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Serological Transplant Diagnostics Introduction
11.1.4 Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Immucor
11.2.1 Immucor Company Detail
11.2.2 Immucor Business Overview
11.2.3 Immucor Serological Transplant Diagnostics Introduction
11.2.4 Immucor Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.2.5 Immucor Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Detail
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Serological Transplant Diagnostics Introduction
11.3.4 Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.3.5 Siemens Healthineers Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Detail
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Serological Transplant Diagnostics Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Serological Transplant Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Detail
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Serological Transplant Diagnostics Introduction
11.6.4 Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.6.5 Agena Bioscience Recent Development
11.7 AVIOQ
11.7.1 AVIOQ Company Detail
11.7.2 AVIOQ Business Overview
11.7.3 AVIOQ Serological Transplant Diagnostics Introduction
11.7.4 AVIOQ Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.7.5 AVIOQ Recent Development
11.8 BAG Healthcare
11.8.1 BAG Healthcare Company Detail
11.8.2 BAG Healthcare Business Overview
11.8.3 BAG Healthcare Serological Transplant Diagnostics Introduction
11.8.4 BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.8.5 BAG Healthcare Recent Development
11.9 BD
11.9.1 BD Company Detail
11.9.2 BD Business Overview
11.9.3 BD Serological Transplant Diagnostics Introduction
11.9.4 BD Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.9.5 BD Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Serological Transplant Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.10.5 Beckman Coulter Recent Development
11.11 Biogenuix
11.11.1 Biogenuix Company Detail
11.11.2 Biogenuix Business Overview
11.11.3 Biogenuix Serological Transplant Diagnostics Introduction
11.11.4 Biogenuix Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.11.5 Biogenuix Recent Development
11.12 DIAGAST
11.12.1 DIAGAST Company Detail
11.12.2 DIAGAST Business Overview
11.12.3 DIAGAST Serological Transplant Diagnostics Introduction
11.12.4 DIAGAST Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.12.5 DIAGAST Recent Development
11.13 Grifols
11.13.1 Grifols Company Detail
11.13.2 Grifols Business Overview
11.13.3 Grifols Serological Transplant Diagnostics Introduction
11.13.4 Grifols Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.13.5 Grifols Recent Development
11.14 Hemo bioscience
11.14.1 Hemo bioscience Company Detail
11.14.2 Hemo bioscience Business Overview
11.14.3 Hemo bioscience Serological Transplant Diagnostics Introduction
11.14.4 Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.14.5 Hemo bioscience Recent Development
11.15 Institut de Biotechnologies
11.15.1 Institut de Biotechnologies Company Detail
11.15.2 Institut de Biotechnologies Business Overview
11.15.3 Institut de Biotechnologies Serological Transplant Diagnostics Introduction
11.15.4 Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.15.5 Institut de Biotechnologies Recent Development
11.16 Lorne Laboratories
11.16.1 Lorne Laboratories Company Detail
11.16.2 Lorne Laboratories Business Overview
11.16.3 Lorne Laboratories Serological Transplant Diagnostics Introduction
11.16.4 Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.16.5 Lorne Laboratories Recent Development
11.17 MTC Invitro
11.17.1 MTC Invitro Company Detail
11.17.2 MTC Invitro Business Overview
11.17.3 MTC Invitro Serological Transplant Diagnostics Introduction
11.17.4 MTC Invitro Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.17.5 MTC Invitro Recent Development
11.18 Quotient Biodiagnostics
11.18.1 Quotient Biodiagnostics Company Detail
11.18.2 Quotient Biodiagnostics Business Overview
11.18.3 Quotient Biodiagnostics Serological Transplant Diagnostics Introduction
11.18.4 Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.18.5 Quotient Biodiagnostics Recent Development
11.19 Tulip Group
11.19.1 Tulip Group Company Detail
11.19.2 Tulip Group Business Overview
11.19.3 Tulip Group Serological Transplant Diagnostics Introduction
11.19.4 Tulip Group Revenue in Serological Transplant Diagnostics Business (2019-2024)
11.19.5 Tulip Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
